US medical device company Abbott has said it plans to launch a new range of 'biowearable' health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring.
The FDA has approved an artificial intelligence-based imaging software developed by Abbott that is used to help physicians carry out procedures like implanting stents to open up narrowed bl
The US and some of the world’s poorest countries may get a low-cost and rapid COVID-19 test ahead of the UK, after the government said it had no immediate plans to order them from manufactu
Novo Nordisk and devices firm Abbott have announced a partnership that aims to make diabetes management easier by linking technologies such as continuous glucose monitoring with connected i
The US Food and Drug Administration has approved an over-the-air software upgrade for Infinity implants manufactured by Abbott, giving devices used in Parkinson’s and essential tremor full-
Abbott's new glucose monitoring device could be used by millions of diabetes patients in the US after government-funded health schemes agreed to pay for it.
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl